Clinical trial Recruiting at 1 site Observational Ages 18 and up

How medicalized residential care influences care plans for vulnerable palliative patients

Official title: Impact of Medicalized Residential Care (LAM) on the Development of Care Plans for Vulnerable Patients in Palliative Care: a Qualitative Study

Run by University Hospital, Strasbourg, France · NCT07342985 · Data updated 2026-11-12

This study will see if living in a medicalized residential facility in Alsace changes how care plans are made for adults receiving palliative care.

More Palliative Care trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity Hospital, Strasbourg, France
Academic / other
Locations1 site (Strasbourg)
StatusRecruiting
StartedOctober 10, 2025
Main results expectedOctober 2026
Study endsOctober 10, 2026
Registry record updatedJanuary 15, 2026
Trial IDNCT07342985 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who reside in one of the two LAM regions of Alsace and are receiving palliative care are the intended participants.

Probably not a fit

Patients who do not live in the specified LAM regions, who are not in palliative care, or who decline to participate are unlikely to receive direct benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will include adults (≥18) receiving palliative care who live in one of two medicalized residential care (LAM) regions of Alsace, France. Researchers will collect clinical and contextual information from medical records and care teams to identify factors that influence the development of care plans. The study focuses on vulnerable patients in palliative settings and excludes those who refuse participation. The goal is to describe patterns and drivers of care planning in LAM settings rather than to test a specific treatment.

Why it matters

Potential benefit: If successful, the findings could help tailor care plans and improve coordination and quality of end-of-life care for vulnerable patients in medicalized residences.

How similar studies have gone: While structured care-planning approaches have improved outcomes in other palliative settings, studies specifically examining care-plan development in French LAM facilities are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult subject (≥18 years old)
* Subject residing in one of the two LAM regions of Alsace (France) at the time of the study and suffering from a palliative-care condition (the nature of the condition (or conditions) is not specified)

Exclusion Criteria:

\- Refusal to participate in the study

Where it's running

  • Service d'Accompagnement et de Soins Palliatifs - CHU de Strasbourg - France
    Strasbourg, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.